Literature DB >> 2838004

Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.

H Repo1, P Koivuranta-Vaara, M Leirisalo-Repo.   

Abstract

Polymorphonuclear leucocyte (PMN) functions (migration in vitro, chemiluminescence, O-2 production, and aggregation) were studied in 32 patients with previous yersinia arthritis (YA). PMNs of 11 HLA-B27 positive patients who had chronic or recurrent inflammatory symptoms showed O-2 production significantly higher than that of PMNs of 11 HLA-B27 positive patients without late manifestations. Also, PMNs of both HLA-B27 positive and negative patients tended to show chemotactic and chemokinetic migration rates higher than those of control cells of healthy HLA-B27 negative subjects. These functional aberrations may play a part in the development of the patients' inflammatory symptoms.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2838004      PMCID： PMC1003544          DOI： 10.1136/ard.47.6.452

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  17 in total

1.  Neutrophil function and HLA-B27.

Authors:  H Repo; M Leirisalo; P Koivuranta; T Osterman; U Kiistala; C G Gahmberg; H Vapaatalo; A Tiilikainen; O Laitinen
Journal:  Br J Rheumatol       Date:  1983-11

2.  Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.

Authors:  C T Pease; J N Fordham; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.

Authors:  H Repo; M Leirisalo; A Tiilikainen; O Laitinen
Journal:  Arthritis Rheum       Date:  1982-06

4.  Enhanced neutrophil migration in vivo HLA B27 positive subjects.

Authors:  P Koivuranta-Vaara; H Repo; M Leirisalo; U Kiistala; T Osterman; H Vapaatalo
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

5.  Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis.

Authors:  H Repo; M Leirisalo-Repo; M Skurnik; A Tiilikainen
Journal:  Med Biol       Date:  1984

6.  Modulating influence of chemotactic factor-induced cell adhesiveness on granulocyte function.

Authors:  J Fehr; C Dahinden
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.

Authors:  M Leirisalo; H Repo; A Tiilikainen; T U Kosunen; O Laitinen
Journal:  Arthritis Rheum       Date:  1980-09

8.  Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme.

Authors:  J G Bender; L C McPhail; D E Van Epps
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects.

Authors:  A Toivanen; K Granfors; R Lahesmaa-Rantala; R Leino; T Ståhlberg; R Vuento
Journal:  Immunol Rev       Date:  1985-08       Impact factor: 12.988

10.  Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis.

Authors:  A F Geczy; L E McGuigan; J S Sullivan; J P Edmonds
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307
View more
  4 in total

1.  The phagocyte oxidative metabolism function in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; D A Vuitton
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis.

Authors:  M Leirisalo-Repo; A Lauhio; H Repo
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

3.  Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence.

Authors:  M Ristola; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

4.  Normal production of neutrophil activating peptide 1/interleukin 8 in monocytes from subjects with previous yersinia triggered reactive arthritis.

Authors:  H Repo; M Ristola; M Leirisalo-Repo; A Walz; M Baggiolini
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.